Press Releases ReWalk Robotics Ltd.

Equities

LFWD

IL0011331076

Market Closed - Nasdaq Other stock markets 04:30:01 2024-05-03 pm EDT			5-day change	1st Jan Change
4.87 ^USD	+2.10%		+2.53%	-10.54%

Apr. 19	ReWalk Robotics Ltd. Appoints Mike Swinford to the Board of Directors	CI
Apr. 01	Lifeward, CMS Working to Finalize Exoskeleton Medicare Payment Rate, CEO Says	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lifeward Announces the Appointment of Mike Swinford to its Board of Directors	Apr. 22	AQ
Lifeward Announces the Appointment of Mike Swinford to its Board of Directors	Apr. 19	GL
Medicare Revises 2024 Fee Schedule to Include Payment Rate for the ReWalk Personal Exoskeleton	Apr. 12	GL
Lifeward CEO Issues Open Letter to Shareholders on Progress to Finalize Exoskeleton Medicare Payment Rate	Apr. 01	GL
VA STAND Act introduced in the United States Senate	Mar. 22	GL
Lifeward Announces Reverse Share Split	Mar. 13	GL
ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy	Mar. 08	GL
Lifeward announces the Centers for Medicare & Medicaid Services (“CMS”) is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the current, more advanced ReWalk Personal Exoskeleton may be considered	Mar. 01	GL
ReWalk: Q4 Earnings Snapshot	Feb. 27	AQ
Lifeward Reports Fourth Quarter and Full Year 2023 Financial Results	Feb. 27	GL
Lifeward Reports Fourth Quarter and Full Year 2023 Financial Results	Feb. 27	AQ
Lifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024	Feb. 20	GL
ReWalk Robotics Transforms Company Identity, Rebrands as Lifeward	Jan. 29	GL
ReWalk Robotics Transforms Company Identity, Rebrands as Lifeward	Jan. 29	AQ
ReWalk Robotics Expands Direct Sales Coverage to Canada	Jan. 12	GL
ReWalk Robotics Ltd. to Present at Sidoti Virtual Investor Conference on January 17	Jan. 11	GL
First ReWalk Personal Exoskeleton Claim Paid by Medicare	Jan. 05	GL
ReWalk Robotics CEO Issues Year-End 2023 Open Letter to Shareholders and Provides 2024 Commercial and Operational Priorities	Jan. 04	GL
ReWalk Robotics CEO Issues Year-End 2023 Open Letter to Shareholders and Provides 2024 Commercial and Operational Priorities	Jan. 04	AQ
ReWalk Robotics Presents on Personal Exoskeleton Pricing at Medicare Public Meeting	Nov. 30	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases ReWalk Robotics Ltd.

Equities

LFWD

IL0011331076

Press Releases

Filters